Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Mannitol renal clearance measurement (procedure) |
Component |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Mannitol adverse reaction |
Causative agent (attribute) |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Allergy to mannitol |
Causative agent (attribute) |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Product containing mannitol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Mannitol 10% infusion solution bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Mannitol 20% infusion solution bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Mannitol 5.0%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Mannitol 5% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Mannitol 10g/100mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Mannitol 15g/100mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Mannitol 20% infusion solution 500mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Mannitol 10g/100mL injection solution 1000mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Mannitol 10g/100mL injection solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Mannitol 5% injection solution 1000mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Mannitol 15g/100mL injection solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Mannitol 20% infusion solution 250 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Mannitol 20% infusion solution 500 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Mannitol 20% infusion solution 500 mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Product containing mannitol and sorbitol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mannitol (substance) |
Inferred relationship |
Some |
2 |
Mannitol hexanitrate |
Is a |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Mannitol-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Cosyntropin 25mcg/mannitol 10mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Cosyntropin 50mcg/mannitol 10mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
|
Allergy to mannitol |
Causative agent (attribute) |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mannitol 50 gram/500 milliliter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mannitol 50 gram/500 milliliter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mannitol 50 gram/250 milliliter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mannitol 50 gram/250 milliliter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mannitol 100 gram/500 milliliter conventional release solution for infusion bag |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mannitol 100 gram/500 milliliter conventional release solution for infusion bag |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing only mannitol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Mannitol and sorbitol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mannitol (substance) |
Inferred relationship |
Some |
2 |
Product containing only mannitol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mannitol 200 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mannitol 200 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mannitol 100 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mannitol 100 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Mannitol 100 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Mannitol 100 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing only mannitol in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing mannitol in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mannitol 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mannitol 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Mannitol hexanitrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Mannitol (substance) |
Inferred relationship |
Some |
|
Product containing precisely mannitol 200 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mannitol 200 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mannitol 100 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mannitol 100 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mannitol (substance) |
Inferred relationship |
Some |
1 |